Related references
Note: Only part of the references are listed.Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies
Marta Pedretti et al.
ATHEROSCLEROSIS (2010)
Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
Caiyun Xuan et al.
BLOOD (2010)
Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma
M. Pedretti et al.
BRITISH JOURNAL OF CANCER (2010)
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Manfred Johannsen et al.
EUROPEAN JOURNAL OF CANCER (2010)
A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies
Alexander Berndt et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFα
Enrica Balza et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma
Katharina Frey et al.
JOURNAL OF UROLOGY (2010)
Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C
Norman J. Hackl et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
Christoph Schliemann et al.
BLOOD (2009)
CD20-targeted tetrameric interferon-α, a novel and potent immunocytokine for the therapy of B-cell lymphomas
Edmund A. Rossi et al.
BLOOD (2009)
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma
Christoph Schliemann et al.
LEUKEMIA RESEARCH (2009)
Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer
Marta Pedretti et al.
LUNG CANCER (2009)
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
Kathrin Schwager et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: Expert opinion
Axel Hauschild et al.
CANCER (2008)
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Jessica Marlind et al.
CLINICAL CANCER RESEARCH (2008)
A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo
Alessandra Villa et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Next generation of immunotherapy for melanoma
John M. Kirkwood et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
New insights into form and function of fibronectin splice variants
E. S. White et al.
JOURNAL OF PATHOLOGY (2008)
Therapy-induced antitumor vaccination by targeting tumor necrosis factor-α to tumor vessels in combination with melphalan
Lorenzo Mortara et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Interferons at age 50: past, current and future impact on biomedicine
Ernest C. Borden et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The extra-domain a of fibronectin is a vascular marker of solid tumors and Metastases
Jascha-N. Rybak et al.
CANCER RESEARCH (2007)
Targeting IFN-α to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities
Tzu-Hsuan Huang et al.
JOURNAL OF IMMUNOLOGY (2007)
Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin
Sophie Astrof et al.
DEVELOPMENTAL BIOLOGY (2007)
Interferon-α and cancer:: Mechanisms of action and new perspectives of clinical use
Maria Ferrantini et al.
BIOCHIMIE (2007)
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis
Manuela Kaspar et al.
CANCER RESEARCH (2007)
A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo
Eveline Trachsel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Eveline Trachsel et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C
Simon S. Brack et al.
CLINICAL CANCER RESEARCH (2006)
Targeted delivery of tumor necrosis factor-α to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin
E Balza et al.
CLINICAL CANCER RESEARCH (2006)
Antibody targeted drugs as cancer therapeutics
D Schrama et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy
C Ebbinghaus et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer
P Tagliaferri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Characterization of the murine alpha interferon gene family
V van Pesch et al.
JOURNAL OF VIROLOGY (2004)
Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver
ML Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin
CM Matter et al.
CIRCULATION RESEARCH (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis
J Kriegsmann et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Selective targeted delivery of TNFα to tumor blood vessels
L Borsi et al.
BLOOD (2003)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes
M Nicolo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
C Halin et al.
NATURE BIOTECHNOLOGY (2002)
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix
B Carnemolla et al.
BLOOD (2002)
Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3
I Peter et al.
MELANOMA RESEARCH (2001)
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
SM Santini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
